- Approved in 2006 by FDA for treatment of patients for with myelodysplastic syndromes (MDS), a group of diseases of the bone marrow characterized by the production of poorly functioning and immature blood cells. Over time, MDS can progress to acute leukemia, or AML
- Generic in 2013
| Product Description | Product Code | CAS Number |
| Decitabine | D-150 | 2352-33-5 |
